Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Treatment at H.U.M
Its approval has already improved the lives of many chronically overweight patients by assisting in safe and consistent weight loss
Both are the same medication, given as a once-weekly subcutaneous injection
They may include counselling sessions, medication management, and support groups
Tirzepatide (Mounjaro), licensed in the UK by the MHRA, demonstrates the clinical benefit of combining GLP-1R and GIPR agonism
US$ 24.66
US$ 28.89
US$ 25.83
US$ 29.32
US$ 25.43
US$ 22.78
US$ 28.50
US$ 23.95
US$ 23.19
